BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 29038086)

  • 1. Radiosurgery for Treatment of Renal Cell Metastases to Spine: A Systematic Review of the Literature.
    Smith BW; Joseph JR; Saadeh YS; La Marca F; Szerlip NJ; Schermerhorn TC; Spratt DE; Younge KC; Park P
    World Neurosurg; 2018 Jan; 109():e502-e509. PubMed ID: 29038086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spine stereotactic body radiotherapy for renal cell cancer spinal metastases: analysis of outcomes and risk of vertebral compression fracture.
    Thibault I; Al-Omair A; Masucci GL; Masson-Côté L; Lochray F; Korol R; Cheng L; Xu W; Yee A; Fehlings MG; Bjarnason GA; Sahgal A
    J Neurosurg Spine; 2014 Nov; 21(5):711-8. PubMed ID: 25170656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reirradiation spine stereotactic body radiation therapy for spinal metastases: systematic review.
    Myrehaug S; Sahgal A; Hayashi M; Levivier M; Ma L; Martinez R; Paddick I; Régis J; Ryu S; Slotman B; De Salles A
    J Neurosurg Spine; 2017 Oct; 27(4):428-435. PubMed ID: 28708043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic body radiotherapy for de novo spinal metastases: systematic review.
    Husain ZA; Sahgal A; De Salles A; Funaro M; Glover J; Hayashi M; Hiraoka M; Levivier M; Ma L; Martínez-Alvarez R; Paddick JI; Régis J; Slotman BJ; Ryu S
    J Neurosurg Spine; 2017 Sep; 27(3):295-302. PubMed ID: 28598293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-fraction stereotactic body radiotherapy for spinal metastases from renal cell carcinoma.
    Balagamwala EH; Angelov L; Koyfman SA; Suh JH; Reddy CA; Djemil T; Hunter GK; Xia P; Chao ST
    J Neurosurg Spine; 2012 Dec; 17(6):556-64. PubMed ID: 23020208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vertebral compression fractures after stereotactic body radiation therapy: a large, multi-institutional, multinational evaluation.
    Jawad MS; Fahim DK; Gerszten PC; Flickinger JC; Sahgal A; Grills IS; Sheehan J; Kersh R; Shin J; Oh K; Mantel F; Guckenberger M;
    J Neurosurg Spine; 2016 Jun; 24(6):928-36. PubMed ID: 26895526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting survival in 37 consecutive patients undergoing de novo stereotactic radiosurgery for contiguous sites of vertebral body metastasis from renal cell carcinoma.
    Sellin JN; Reichardt W; Bishop AJ; Suki D; Rhines LD; Settle SH; Brown PD; Li J; Rao G; Chang EL; Tatsui CE
    J Neurosurg Spine; 2015 Jan; 22(1):52-9. PubMed ID: 25360530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
    Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A
    J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technique for stereotactic body radiotherapy for spinal metastases.
    Foote M; Letourneau D; Hyde D; Massicotte E; Rampersaud R; Fehlings M; Fisher C; Lewis S; Macchia NL; Yu E; Laperriere NJ; Sahgal A
    J Clin Neurosci; 2011 Feb; 18(2):276-9. PubMed ID: 21147535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for vertebral compression fracture after spine stereotactic body radiation therapy: Long-term results of a prospective phase 2 study.
    Mantel F; Sweeney RA; Klement RJ; Hawkins MA; Belderbos J; Ahmed M; Toussaint A; Polat B; Flentje M; Guckenberger M
    Radiother Oncol; 2019 Dec; 141():62-66. PubMed ID: 31526672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligo metastatic renal cell carcinoma: stereotactic body radiation therapy, if, when and how?
    Marvaso G; Corrao G; Oneta O; Pepa M; Zaffaroni M; Corso F; Gandini S; Cecconi A; Zerini D; Mazzola GC; Augugliaro M; Cossu Rocca M; Verri E; Cattani F; La Fauci F; Bergamaschi L; Luzzago S; Mistretta AF; Musi G; Nolè F; De Cobelli O; Orecchia R; Jereczek-Fossa BA
    Clin Transl Oncol; 2021 Aug; 23(8):1717-1726. PubMed ID: 33687659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of spinal metastases from renal cell carcinoma using stereotactic body radiotherapy.
    Nguyen QN; Shiu AS; Rhines LD; Wang H; Allen PK; Wang XS; Chang EL
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1185-92. PubMed ID: 19632064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early Tissue Effects of Stereotactic Body Radiation Therapy for Spinal Metastases.
    Steverink JG; Willems SM; Philippens MEP; Kasperts N; Eppinga WSC; Versteeg AL; van der Velden JM; Faruqi S; Sahgal A; Verlaan JJ
    Int J Radiat Oncol Biol Phys; 2018 Apr; 100(5):1254-1258. PubMed ID: 29439885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of stereotactic radiotherapy for cranial and extracranial metastatic renal cell carcinoma: a systematic review.
    Kothari G; Foroudi F; Gill S; Corcoran NM; Siva S
    Acta Oncol; 2015 Feb; 54(2):148-57. PubMed ID: 25140860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of different fractions in stereotactic body radiotherapy for spinal metastases: A systematic review.
    Gong Y; Xu L; Zhuang H; Jiang L; Wei F; Liu Z; Li Y; Yu M; Ni K; Liu X
    Cancer Med; 2019 Oct; 8(14):6176-6184. PubMed ID: 31489788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcome of vertebral compression fracture after single fraction spine radiosurgery for spinal metastases.
    Germano IM; Carai A; Pawha P; Blacksburg S; Lo YC; Green S
    Clin Exp Metastasis; 2016 Feb; 33(2):143-9. PubMed ID: 26578533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spine stereotactic radiosurgery with concurrent tyrosine kinase inhibitors for metastatic renal cell carcinoma.
    Miller JA; Balagamwala EH; Angelov L; Suh JH; Rini B; Garcia JA; Ahluwalia M; Chao ST
    J Neurosurg Spine; 2016 Dec; 25(6):766-774. PubMed ID: 27391397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superior target delineation for stereotactic body radiotherapy of bone metastases from renal cell carcinoma on MRI compared to CT.
    Prins FM; van der Velden JM; Gerlich AS; Kotte ANTJ; Eppinga WSC; Kasperts N; Verlaan JJ; Pameijer FA; Kerkmeijer LGW
    Ann Palliat Med; 2017 Dec; 6(Suppl 2):S147-S154. PubMed ID: 28866897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local control rates of metastatic renal cell carcinoma (RCC) to the bone using stereotactic body radiation therapy: Is RCC truly radioresistant?
    Amini A; Altoos B; Bourlon MT; Bedrick E; Bhatia S; Kessler ER; Flaig TW; Fisher CM; Kavanagh BD; Lam ET; Karam SD
    Pract Radiat Oncol; 2015; 5(6):e589-e596. PubMed ID: 26142027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging-Based Outcomes for 24 Gy in 2 Daily Fractions for Patients with de Novo Spinal Metastases Treated With Spine Stereotactic Body Radiation Therapy (SBRT).
    Tseng CL; Soliman H; Myrehaug S; Lee YK; Ruschin M; Atenafu EG; Campbell M; Maralani P; Yang V; Yee A; Sahgal A
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(3):499-507. PubMed ID: 30003994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.